{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:34:51Z","timestamp":1776285291293,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1136\/annrheumdis-2014-206691","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T15:24:57Z","timestamp":1424964297000},"page":"696-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Disease specificity of autoantibodies to cytosolic 5\u2032-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases"],"prefix":"10.1016","volume":"75","author":[{"given":"Megan K","family":"Herbert","sequence":"first","affiliation":[]},{"given":"Judith","family":"Stammen-Vogelzangs","sequence":"additional","affiliation":[]},{"given":"Marcel M","family":"Verbeek","sequence":"additional","affiliation":[]},{"given":"Anke","family":"Rietveld","sequence":"additional","affiliation":[]},{"given":"Ingrid E","family":"Lundberg","sequence":"additional","affiliation":[]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[]},{"given":"Janine A","family":"Lamb","sequence":"additional","affiliation":[]},{"given":"Robert G","family":"Cooper","sequence":"additional","affiliation":[]},{"given":"Mark","family":"Roberts","sequence":"additional","affiliation":[]},{"given":"Umesh A","family":"Badrising","sequence":"additional","affiliation":[]},{"given":"Jan L","family":"De Bleecker","sequence":"additional","affiliation":[]},{"given":"Pedro M","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Michael G","family":"Hanna","sequence":"additional","affiliation":[]},{"given":"Lenka","family":"Plestilova","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-0713","authenticated-orcid":false,"given":"Jiri","family":"Vencovsky","sequence":"additional","affiliation":[]},{"given":"Baziel G","family":"van Engelen","sequence":"additional","affiliation":[]},{"given":"Ger J M","family":"Pruijn","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2014-206691_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mayocp.2012.10.017","article-title":"Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations","volume":"88","author":"Ernste","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1136\/annrheumdis-2014-206691_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3899\/jrheum.120682","article-title":"Classification, diagnosis, and management of idiopathic inflammatory myopathies","volume":"40","author":"Lazarou","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2014-206691_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-013-0335-1","article-title":"Autoantibodies in polymyositis and dermatomyositis","volume":"15","author":"Ghirardello","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/annrheumdis-2014-206691_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/PL00007850","article-title":"Clinical and serological characteristics of 125 Dutch myositis patients","volume":"249","author":"Hengstman","year":"2002","journal-title":"J Neurol"},{"key":"10.1136\/annrheumdis-2014-206691_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1136\/annrheumdis-2014-206691_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis","volume":"73","author":"Larman","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1136\/annrheumdis-2014-206691_bib7","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/brain\/awr217","article-title":"A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities","volume":"134","author":"Cox","year":"2011","journal-title":"Brain"},{"key":"10.1136\/annrheumdis-2014-206691_bib8","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"key":"10.1136\/annrheumdis-2014-206691_bib9","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00415-005-0884-y","article-title":"Inclusion body myositis","volume":"252","author":"Badrising","year":"2005","journal-title":"J Neurol"},{"key":"10.1136\/annrheumdis-2014-206691_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-013-0329-z","article-title":"Update on treatment of inclusion body myositis","volume":"15","author":"Breithaupt","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/annrheumdis-2014-206691_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11910-012-0321-4","article-title":"Inclusion body myositis","volume":"13","author":"Dimachkie","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1136\/annrheumdis-2014-206691_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/NEN.0b013e31826183c8","article-title":"Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis","volume":"71","author":"Askanas","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1136\/annrheumdis-2014-206691_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/WCO.0b013e32833d3897","article-title":"Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers","volume":"23","author":"Weihl","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1136\/annrheumdis-2014-206691_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00401-009-0554-8","article-title":"Increased plasma amyloid-\u03b242 protein in sporadic inclusion body myositis","volume":"118","author":"Abdo","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1136\/annrheumdis-2014-206691_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2051-5960-1-29","article-title":"Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies","volume":"1","author":"Hiniker","year":"2013","journal-title":"Acta Neuropathol Comm."},{"key":"10.1136\/annrheumdis-2014-206691_bib16","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1212\/01.wnl.0000192129.65677.87","article-title":"Inflammatory, immune, and viral aspects of inclusion-body myositis","volume":"66","author":"Dalakas","year":"2006","journal-title":"Neurology"},{"key":"10.1136\/annrheumdis-2014-206691_bib17","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","article-title":"Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis","volume":"63","author":"Badrising","year":"2004","journal-title":"Neurology"},{"key":"10.1136\/annrheumdis-2014-206691_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1136\/annrheumdis-2014-206691_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2012.04.007","article-title":"Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): A population control study","volume":"249","author":"Rojana-Udomsart","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1136\/annrheumdis-2014-206691_bib20","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1074\/jbc.M011218200","article-title":"Human Cytosolic 5\u2032-Nucleotidase I: Characterization and role in nucleoside analog resistance","volume":"276","author":"Hunsucker","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1136\/annrheumdis-2014-206691_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/abbs\/gmp011","article-title":"Expression of cytosolic 5\u2032 nucleotidase does not correlate with expression of oxidative metabolism marker: myoglobine in human skeletal muscles","volume":"41","author":"Lechward","year":"2009","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1136\/annrheumdis-2014-206691_bib22","series-title":"Diagnostic criteria for neuromuscular disorders","first-page":"81","article-title":"Inclusion body myositis","author":"Verschuuren","year":"1997"},{"key":"10.1136\/annrheumdis-2014-206691_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.nmd.2010.03.014","article-title":"International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009","volume":"20","author":"Benveniste","year":"2010","journal-title":"Neuromusc Dis"},{"key":"10.1136\/annrheumdis-2014-206691_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00415-005-0683-5","article-title":"High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders","volume":"252","author":"Hengstman","year":"2005","journal-title":"J Neurol"},{"key":"10.1136\/annrheumdis-2014-206691_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/rheumatology\/41.4.440","article-title":"Primary Sj\u00f6gren's syndrome associated with inclusion body myositis","volume":"41","author":"Kanellopoulos","year":"2002","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2014-206691_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.clineuro.2011.03.016","article-title":"The association of sporadic inclusion body myositis and Sj\u00f6gren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype","volume":"113","author":"Rojana-Udomsart","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1136\/annrheumdis-2014-206691_bib27","doi-asserted-by":"crossref","first-page":"e20266","DOI":"10.1371\/journal.pone.0020266","article-title":"Autoantibodies against a 43 KDa muscle protein in inclusion body myositis","volume":"6","author":"Salajegheh","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724019137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724019137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2014-206691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T07:04:43Z","timestamp":1736060683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724019137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0003496724019137"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2014-206691","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease specificity of autoantibodies to cytosolic 5\u2032-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2014-206691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}